Actionable news
0
All posts from Actionable news
Actionable news in VRX: VALEANT PHARMACEUTICALS INTERNATIONAL,

Valeant Pharmaceuticals (VRX) Stock Dives Despite Earnings Beat, Raised Guidance

NEW YORK (TheStreet) -- Valeant Pharmaceuticals (VRX - Get Report) stock is down by 5.34% to $168.08 in mid-morning trading on Monday, after the company reported its 2015 third quarter earnings results and raised its full-year guidance.

The pharmaceutical and medical device company reported earnings of $2.74 per share, up from $2.11 per share for the 2014 third quarter.

Revenue increased by 36% year over year, to $2.8 billion for the most recent quarter.

STOCKS TO BUY: TheStreet's Stocks Under $10 has identified a handful of stocks with serious upside potential. See them FREE for 14-days.

Valeant Pharmaceuticals had been forecast to report earnings of $2.72 per share on revenue of $2.78 billion by...


More